DMPHF OTC
Dermapharm Holding SE
1W: +0.0%
1M: +0.0%
3M: -10.0%
YTD: +20.6%
1Y: +20.6%
3Y: +17.4%
$47.69
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$2.1B
-3.7% ▼
5Y CAGR: +14.8%
Total Liabilities
$1.5B
-8.9% ▼
5Y CAGR: +14.1%
Shareholders Equity
$604M
+12.1% ▲
5Y CAGR: +16.7%
Cash & Investments
$122M
-23.7% ▼
5Y CAGR: +1.0%
Total Debt
$980M
-9.3% ▼
5Y CAGR: +12.1%
Net Debt
$858M
-6.9% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $121M | $160M | $150M | $159M | $121M |
| Short-Term Investments | $1M | $12M | $11M | $818K | $511K |
| Cash & ST Investments | $122M | $172M | $161M | $160M | $122M |
| Net Receivables | $59M | $76M | $100M | $95M | $105M |
| Inventory | $203M | $241M | $252M | $317M | $340M |
| Other Current Assets | $13M | $27M | $22M | $47M | $16M |
| Total Current Assets | $400M | $519M | $534M | $630M | $593M |
| Property, Plant & Equip. | $200M | $222M | $226M | $331M | $315M |
| Goodwill & Intangibles | $564M | $560M | $576M | $1.0B | $1.1B |
| Long-Term Investments | $60M | $94M | $65M | $75M | $82M |
| Other Non-Current Assets | $1M | $12M | $1K | $104M | $510K |
| Total Non-Current Assets | $824M | $888M | $879M | $1.5B | $1.5B |
| Total Assets | $1.2B | $1.4B | $1.4B | $2.2B | $2.1B |
| — Liabilities — | |||||
| Accounts Payable | $50M | $52M | $56M | $87M | $95M |
| Short-Term Debt | $22M | $2M | $2M | $111M | $85M |
| Deferred Revenue | $55M | $97M | $155M | $942K | $0 |
| Other Current Liabilities | -$37M | -$44M | -$53M | $96M | $75M |
| Total Current Liabilities | $133M | $156M | $218M | $394M | $327M |
| Long-Term Debt | $570M | $566M | $502M | $951M | $877M |
| Other Non-Current Liab. | $186M | $177M | $151M | $268M | $132M |
| Total Non-Current Liabilities | $767M | $752M | $663M | $1.2B | $1.1B |
| Total Liabilities | $900M | $907M | $880M | $1.6B | $1.5B |
| — Equity — | |||||
| Common Stock | $54M | $54M | $54M | $54M | $54M |
| Retained Earnings | $177M | $338M | $355M | $367M | $433M |
| Accumulated OCI | -$10M | $106M | $122M | $118M | $117M |
| Total Stockholders Equity | $322M | $497M | $532M | $539M | $604M |
| Total Liabilities & Equity | $1.2B | $1.4B | $1.4B | $2.2B | $2.1B |
| — Key Metrics — | |||||
| Total Debt | $607M | $580M | $516M | $1.1B | $980M |
| Net Debt | $486M | $420M | $367M | $922M | $858M |
| Total Investments | $61M | $106M | $77M | $75M | $83M |